Abstract:[Objective]H9N2 subtype avian influenza virus can spread between the guinea pig after passages in guinea pigs continuously for 9 generations, showing that the capacity of H9N2 subtype avian influenza virus infection in mammals as well as the <br> spreading capacity between mammals are still very strong. Thus, this experiment using this strain virus A/Chicken/Jinan/Li-2/2010 (H9N2), JN, to study the molecular basis of H9N2 subtype influenza virus variation, and screen the pathogenicity related amino acid sites.[Method]An H9N2 subtype AIV was serial passaged in the lung of mice to acquire the variant strains JN-P9-2-M1, the mice were dissected, the lungs were removed, after grinding and centrifugation, the mice of next generation were inoculated intranasally, after nine generations of spreading, MDCK cells were used for virus multiplication. Then the full-length sequences of JN-P5-2-M1 and JN-P9-2-M1eight segments were amplified, cloned and analyzed. Amino acids encoded by each gene were deduced, compared to JN primary virus (P0) , and the nucleotide and amino acid changes in virus passages were obtained. The mice were dissected, the lung, liver, spleen, kidneys, brain and intestines were obtained, and the virus titer of tissues was titrated. Mice were anesthetized, and each virus dilution was used to inoculate intranasally three mice for detecting the survival rate and morbidity of mice. Lungs of mice were collected, then the pathological and immunohistochemical staining was made to compare the JN and JN-P9-2-M1 virus.[Result] JN-P9-2-M1 had high pathogenicity to mice, its MLD50 was 103.5EID50, when had a 106EID50, 105EID50, 104EID50 dose in mice, its survival rate was 0, at least 1000 times higher than JN, the JN in mice was not lethal. When the dose of JN-P9-2-M1 was 106-103EID50 for mice, the body weight was significantly reduced, and the clinical symptoms were obvious. After inoculation for 3-8 d the mice showed listless, hair messy, shortness of breath, arched, etc., but when the mice were inoculated with 106EID50JN virus, the mice body weight change rates were similar to the negative group. JN-P5-2-M1, JN-P9-2-M1, and JN could binding to SAa-2,6Gal receptor, like B influenza virus. JN virus was detected only in the lungs of mice, but JN-P9-2-M1 not only in the lungs of mice but also could be detected in liver, spleen, kidney and brain.[Conclusion]JN-P9-2-M1’s pathogenicity in mice significantly improved, compared with the original drug increased by at least 1 000 times. The three amino acid sites PB2 E627K, HA N313D, and HA N496S might be the reasons of preliminary improvement of the virus virulence in mice, and the two acid sites PA L342I and NA N218T might be possible to further improve the virus virulence in mice.

Vitamin D Receptor and 1Α-Hydroxylase Are Highly Expressed in Lungs of Mice Infected with H9N2 Avian Influenza Viruses.

Amino Acid Substitutions HA A150V, PA A343T, and PB2 E627K Increase the Virulence of H5N6 Influenza Virus in Mice

Multiple Amino Acid Substitutions Involved in the Adaptation of Avian-Origin Influenza A (H10N7) Virus in Mice

Avian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitor.

Adaptive Amino Acid Substitutions Enhance the Virulence of an Avian-Origin H6N1 Influenza Virus in Mice

Acute Respiratory Distress Syndrome Induced by H9N2 Virus in Mice

Amino Acid Substitutions Involved in the Adaptation of a Novel H7N7 Avian Influenza Virus in Mice.

Multiple Amino Acid Substitutions Are Involved in the Adaptation of H9N2 Avian Influenza Virus to Mice.

The Adaptation of H9N2 Subtype AIV in Mouse and Analysis of Amino Acid Mutation

Enhanced Pathogenicity and Transmissibility of H9N2 Avian Influenza Virus in Mammals by Hemagglutinin Mutations Combined with PB2-627K.

Comparative analysis of selected innate immune-related genes following infection of immortal DF-1 cells with highly pathogenic (H5N1) and low pathogenic (H9N2) avian influenza viruses

Pathogenesis and Immunogenicity of an Avian H9N2 Influenza Virus Isolated from Human.

Adaptive Amino Acid Substitutions Enable Transmission of an H9N2 Avian Influenza Virus in Guinea Pigs

Mouse Lung‐adapted Mutation of E190G in Hemagglutinin from H5N1 Influenza Virus Contributes to Attenuation in Mice

All-trans retinoic acid increases the pathogenicity of the H9N2 influenza virus in mice

Amino Acid Substitutions Involved in the Adaptation of a Novel Highly Pathogenic H5N2 Avian Influenza Virus in Mice

RNA-Seq Analysis of Influenza A Virus-Induced Transcriptional Changes in Mice Lung and Its Possible Implications for the Virus Pathogenicity in Mice

Negative Regulators of Inflammation Response to the Dynamic Expression of Cytokines in DF-1 and MDCK Cells Infected by Avian Influenza Viruses

A Single Mutation at Position 190 in Hemagglutinin Enhances Binding Affinity for Human Type Sialic Acid Receptor and Replication of H9N2 Avian Influenza Virus in Mice

Mouse-adapted H9N2 Avian Influenza Virus Causes Systemic Infection in Mice

Comparison of H7N9 and H9N2 influenza infections in mouse model unravels the importance of early innate immune response in host protection